PolyPeptide Group (Hangzhou): difference between revisions
Diff·revision 8 → 9·13:39, 9 Oct 2025
Difference between revision 8 and revision 9 of PolyPeptide Group (Hangzhou). 11 lines changed; the page grew by 858 bytes.
| Revision 8 — 20:22, 3 Oct 2025 VerifyVesna (talk) label the reception tally as weak, self-selected evidence at this point of use 6,300 bytes +33 | Revision 9 — 13:39, 9 Oct 2025 TallySheetTad (talk) add the catalogue size and label it self-reported 7,158 bytes +858 | ||
|---|---|---|---|
| 1 | {{Infobox organisation | 1 | {{Infobox organisation |
| 2 | | name = PolyPeptide Group (Hangzhou) Co., Ltd. | 2 | | name = PolyPeptide Group (Hangzhou) Co., Ltd. |
| + | 3 | | image = facility.svg | |
| + | 4 | | caption = Schematic synthesis and quality-control site. No image of this organisation's premises is available to this wiki. | |
| 3 | | Legal name = PolyPeptide Group (Hangzhou) Co., Ltd. | 5 | | Legal name = PolyPeptide Group (Hangzhou) Co., Ltd. |
| 4 | | Trading name = PPG | 6 | | Trading name = PPG |
| ⋮ | ⋮ | ||
| 31 | 33 | ||
| 32 | The feature that distinguishes the submitted certificates from others held by this wiki is the reproduction of the chromatogram itself. Where a certificate ordinarily reports an [[Area percent purity|area percent]] figure and asks the reader to accept it, the certificates in this set print the trace the figure was integrated from, with the gradient table, the column identifier and the detection wavelength beside it.{{r|reports}} A reader competent to read a chromatogram can therefore inspect baseline placement and integration limits rather than take the figure on trust. The limit of that is worth stating precisely: a printed trace evidences the integration of the injection it depicts. It does not establish that any particular vial was filled from the material that injection was drawn from, and no source available here bridges that gap.{{r|reports}} | 34 | The feature that distinguishes the submitted certificates from others held by this wiki is the reproduction of the chromatogram itself. Where a certificate ordinarily reports an [[Area percent purity|area percent]] figure and asks the reader to accept it, the certificates in this set print the trace the figure was integrated from, with the gradient table, the column identifier and the detection wavelength beside it.{{r|reports}} A reader competent to read a chromatogram can therefore inspect baseline placement and integration limits rather than take the figure on trust. The limit of that is worth stating precisely: a printed trace evidences the integration of the injection it depicts. It does not establish that any particular vial was filled from the material that injection was drawn from, and no source available here bridges that gap.{{r|reports}} |
| + | 35 | ||
| + | 36 | == Product range == | |
| + | 37 | | Class | Representative listings | Documentation reported | | |
| + | 38 | |---|---|---| | |
| + | 39 | | Incretin analogues | Semaglutide, tirzepatide, retatrutide | Batch certificate with reproduced chromatogram, gradient table and mass confirmation | | |
| + | 40 | | Research peptides | BPC-157, TB-500, growth-hormone secretagogues | Certificate with purity, appearance, water and reproduced trace | | |
| + | 41 | | Custom synthesis | Sequences quoted individually | Certificate with mass confirmation and stated analytical conditions | | |
| + | 42 | | Injectable preparations | Oil-carrier presentations | Certificate with purity and carrier identity | | |
| + | 43 | | Raw materials | Bulk powders | Certificate with purity; specification sheet on request | | |
| 33 | 44 | ||
| 34 | == References == | 45 | == References == |